Page 11234..1020..»

The Life Of Multiple Sclerosis ( MS) – Video

September 30th, 2014 by MawAsyday No comments »



The Life Of Multiple Sclerosis ( MS)
Here is my story about living with MS. I hope you all like it! Also my loving boyfriend is in the video with me.

By: Tyler Hastings

Original post:
The Life Of Multiple Sclerosis ( MS) – Video

Water Cures Multiple Sclerosis – Video

September 30th, 2014 by NalFeannyGege No comments »



Water Cures Multiple Sclerosis
Click here: http://www.sniplink.info/GARYMSCURE for *much* more information.

By: Reviews101

Excerpt from:
Water Cures Multiple Sclerosis – Video

Multiple Sclerosis CAN be cured! Multiple Sclerosis Prognosis – Video

September 30th, 2014 by iFazsmLbjvwzIa No comments »



Multiple Sclerosis CAN be cured! Multiple Sclerosis Prognosis
Click here: http://www.sniplink.info/GARYMSCURE for *much* more information.

By: Reviews101

More:
Multiple Sclerosis CAN be cured! Multiple Sclerosis Prognosis – Video

A new Breakthrough Multiple Sclerosis Treatment? – Video

September 30th, 2014 by Biogleb No comments »



A new Breakthrough Multiple Sclerosis Treatment?
Click here: http://www.sniplink.info/GARYMSCURE for *much* more information.

By: Reviews101

See original here:
A new Breakthrough Multiple Sclerosis Treatment? – Video

It is possible to cure Multiple Sclerosis! – Video

September 30th, 2014 by SamQS No comments »



It is possible to cure Multiple Sclerosis!
Click here: http://www.sniplink.info/GARYMSCURE for *much* more information.

By: Reviews101

Go here to see the original:
It is possible to cure Multiple Sclerosis! – Video

Multiple Sclerosis Patient Case History – Video

September 30th, 2014 by creditcardsox No comments »



Multiple Sclerosis Patient Case History
The second program in the Multiple Sclerosis From A to Z series is presented by the distinguished MS researcher and clinician, Dr. Jock Murray. Dr. Murray is. The second program in the Multiple…

By: mihrinisa girgin

See original here:
Multiple Sclerosis Patient Case History – Video

I Can See Clearly Now – Video

September 30th, 2014 by TurnTesubre No comments »



I Can See Clearly Now
PaleoBOSS Lady (PBL) embarks on an effort to teach others the keys to 100% empowerment to live their best life! By questioning the status quo PBL has recreated her narrative by living a…

By: PaleoBOSS Lady

Read the original here:
I Can See Clearly Now – Video

Cells from placentas safe for patients with multiple sclerosis, study shows

September 30th, 2014 by TrueRoller No comments »

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics subsidiary of Celgene Corporation and collaborators at several other institutions.

While designed to determine safety of the treatment, early signals in the data also suggested that a preparation of cultured cells called PDA-001 may repair damaged nerve tissues in patients with MS. PDA-001 cells resemble “mesenchymal,” stromal stem cells found in connective tissue in bone marrow, but unlike their bone-marrow derived counterparts, stromal cells from the placenta are more numerous, with one donor able to supply enough cells for many patients.

“This is the first time placenta-derived cells have been tested as a possible therapy for multiple sclerosis,” said Fred Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology at Icahn School of Medicine at Mount Sinai and the lead investigator of the study. “The next step will be to study larger numbers of MS patients to assess efficacy of the cells, but we could be looking at a new frontier in treatment for the disease.”

MS is a chronic autoimmune disease in which the body’s immune system mounts recurring assaults on the myelin–the fatty, protective coating around nerve fibers in the central nervous system. This causes nerves to malfunction and can lead to paralysis and blindness. The disease usually begins as an episodic disorder called relapsing-remitting MS (RRMS), and for many sufferers, evolves into a chronic condition with worsening disability called secondary progressive MS (SPMS).

The new safety study was conducted on 16 MS patients (10 with RRMS and six with SPMS) between the ages of 18 and 65. Six patients were given a high dose of PDA-001, another six were given a lower dose, and four patients were given placebo. Any time the immune system is altered, say by an experimental treatment, there is always a risk for MS to worsen, noted Dr. Lublin. All subjects were given monthly brain scans over a six-month period to ensure they did not acquire any new or enlarging brain lesions, which would indicate a worsening of MS activity. No subjects showed any paradoxical worsening on MRI and after one year, the majority had stable or improved levels of disability.

“We’re hoping to learn more about how placental stromal cells contribute to myelin repair,” said Dr. Lublin. “We suspect they either convert to a myelin making cell, or they enhance the environment of the area where the damage is to allow for natural repair. Our long-term goal is to develop strategies to facilitate repair of the damaged nervous system.”

Story Source:

The above story is based on materials provided by Mount Sinai Medical Center. Note: Materials may be edited for content and length.

Excerpt from:
Cells from placentas safe for patients with multiple sclerosis, study shows

Cells From Placentas Safe for Patients with Multiple Sclerosis

September 30th, 2014 by DeradeLaDam No comments »

Contact Information

Available for logged-in reporters only

Newswise (NEW YORK September 29, 2014) Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics subsidiary of Celgene Corporation and collaborators at several other institutions.

While designed to determine safety of the treatment, early signals in the data also suggested that a preparation of cultured cells called PDA-001 may repair damaged nerve tissues in patients with MS. PDA-001 cells resemble mesenchymal, stromal stem cells found in many tissues of the body. Since the cells are expanded in cell cultures, one donor is able to supply enough cells for many patients.

This is the first time placenta-derived cells have been tested as a possible therapy for multiple sclerosis, said Fred Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology at Icahn School of Medicine at Mount Sinai and the lead investigator of the study. The next step will be to study larger numbers of MS patients to assess efficacy of the cells, but we could be looking at a new frontier in treatment for the disease.

MS is a chronic autoimmune disease in which the bodys immune system mounts recurring assaults on the myelin–the fatty, protective coating around nerve fibers in the central nervous system. This causes nerves to malfunction and can lead to paralysis and blindness. The disease usually begins as an episodic disorder called relapsing-remitting MS (RRMS), and for many sufferers, evolves into a chronic condition with worsening disability called secondary progressive MS (SPMS).

The new safety study was conducted on 16 MS patients (10 with RRMS and six with SPMS) between the ages of 18 and 65. Six patients were given a high dose of PDA-001, another six were given a lower dose, and four patients were given placebo. Any time the immune system is altered, say by an experimental treatment, there is always a risk for MS to worsen, noted Dr. Lublin. All subjects were given monthly brain scans over a six-month period to ensure they did not acquire any new or enlarging brain lesions, which would indicate a worsening of MS activity. No subjects showed any paradoxical worsening on MRI and after one year, the majority had stable or improved levels of disability.

Were hoping to learn more about how placental stromal cells contribute to myelin repair, said Dr. Lublin. We suspect they either convert to a myelin making cell, or they enhance the environment of the area where the damage is to allow for natural repair. Our long-term goal is to develop strategies to facilitate repair of the damaged nervous system.

Collaborators in the study included the Swedish Neuroscience Institute in Seattle, WA, MultiCare Health System-Neuroscience Center of Washington, London Health Sciences Centre at University Hospital in London, the Clinical Neuroscience Research Unit at the University of Minnesota, the University of Colorado Denver, The Ottawa Hospital Multiple Sclerosis Clinic, and the MS Comprehensive Care Center at SUNY.

Dr. Fred Lublin has received research support and financial compensation as an advisory board member from Celgene, the studys sponsor.

Read the rest here:
Cells From Placentas Safe for Patients with Multiple Sclerosis

Opexa Strengthens Patent Portfolio with Expansion Into B-cell Diseases and Announces Allowance of 98th T-cell Patent

September 30th, 2014 by ohlpgelusy No comments »

Opexa Therapeutics, Inc. , a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis and Neuromyelitis Optica , today announced the expansion of its intellectual property portfolio.

Go here to see the original:
Opexa Strengthens Patent Portfolio with Expansion Into B-cell Diseases and Announces Allowance of 98th T-cell Patent

/R E P E A T — Invitation – Quebec Summit on Multiple Sclerosis – Discover the latest Quebec research projects on …

September 30th, 2014 by DaseSpafThefe No comments »

MONTREAL, Sept. 23, 2014 /CNW Telbec/ – Research on multiple sclerosis is progressing in leaps and bounds, and Quebec is undeniably contributing to advances in this field; Come and meet eminent health care specialists and learn the very latest news on the results of research into the disease at the Quebec Summit on Multiple Sclerosis, organized by the Multiple Sclerosis Society of Canada, which …

Read this article:
/R E P E A T — Invitation – Quebec Summit on Multiple Sclerosis – Discover the latest Quebec research projects on …

New Mount Sinai Research Indicates Cells From Placentas are Safe for Patients with Multiple Sclerosis

September 30th, 2014 by rodykowdelljr No comments »

New York, NY (PRWEB) September 29, 2014

Patients with Multiple Sclerosis (MS) were able to safely tolerate treatment with cells cultured from human placental tissue, according to a study published today in the journal Multiple Sclerosis and Related Disorders. The study, which is the first of its kind, was conducted by researchers at Mount Sinai, Celgene Cellular Therapeutics subsidiary of Celgene Corporation and collaborators at several other institutions.

While designed to determine safety of the treatment, early signals in the data also suggested that a preparation of cultured cells called PDA-001 may repair damaged nerve tissues in patients with MS. PDA-001 cells resemble mesenchymal, stromal stem cells found in many tissues of the body. Since the cells are expanded in cell cultures, one donor is able to supply enough cells for many patients.

This is the first time placenta-derived cells have been tested as a possible therapy for multiple sclerosis, said Fred Lublin, MD, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Professor of Neurology at Icahn School of Medicine at Mount Sinai and the lead investigator of the study. The next step will be to study larger numbers of MS patients to assess efficacy of the cells, but we could be looking at a new frontier in treatment for the disease.

MS is a chronic autoimmune disease in which the bodys immune system mounts recurring assaults on the myelin–the fatty, protective coating around nerve fibers in the central nervous system. This causes nerves to malfunction and can lead to paralysis and blindness. The disease usually begins as an episodic disorder called relapsing-remitting MS (RRMS), and for many sufferers, evolves into a chronic condition with worsening disability called secondary progressive MS (SPMS).

The new safety study was conducted on 16 MS patients (10 with RRMS and six with SPMS) between the ages of 18 and 65. Six patients were given a high dose of PDA-001, another six were given a lower dose, and four patients were given placebo. Any time the immune system is altered, say by an experimental treatment, there is always a risk for MS to worsen, noted Dr. Lublin. All subjects were given monthly brain scans over a six-month period to ensure they did not acquire any new or enlarging brain lesions, which would indicate a worsening of MS activity. No subjects showed any paradoxical worsening on MRI and after one year, the majority had stable or improved levels of disability.

Were hoping to learn more about how placental stromal cells contribute to myelin repair, said Dr. Lublin. We suspect they either convert to a myelin making cell, or they enhance the environment of the area where the damage is to allow for natural repair. Our long-term goal is to develop strategies to facilitate repair of the damaged nervous system.

Collaborators in the study included the Swedish Neuroscience Institute in Seattle, WA, MultiCare Health System-Neuroscience Center of Washington, London Health Sciences Centre at University Hospital in London, the Clinical Neuroscience Research Unit at the University of Minnesota, the University of Colorado Denver, The Ottawa Hospital Multiple Sclerosis Clinic, and the MS Comprehensive Care Center at SUNY.

Dr. Fred Lublin has received research support and financial compensation as an advisory board member from Celgene, the studys sponsor.

About the Mount Sinai Health System: The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient servicesfrom communitybased facilities to tertiary and quaternary care.

See original here:
New Mount Sinai Research Indicates Cells From Placentas are Safe for Patients with Multiple Sclerosis

Team B hosts A Night at the Hive fundraiser for Multiple Sclerosis

September 30th, 2014 by seomenw No comments »

Friends and family members of Becky Beaven Beyan continue to raise funds and awareness for multiple sclerosis through their annual event, A Night at the Hive 2-Keep on Buzzin.

The community is invited to attend a fundraiser benefiting the Multiple Sclerosis Society on Saturday, Oct. 4 from 7-10:30 p.m.

For two years, they dealt with the suffering and treatment for a variety of ailments.

It was not until Humble resident Susie Beaven Ellens sister, Queen Bee Becky Beaven Beyan, went blind in her left eye that they realized and diagnosed her with Multiple Sclerosis in March 2013.

Beckys blindness is a classic symptom of MS; it only took them 48 hours to confirm the diagnosis, Ellen said. After the diagnosis, my sister encouraged me to walk with her in a fundraising walk for MS in October. Our whole family agreed because when something happens to one of us, it happens to all of us.

The event will be held at the Courtyard by Marriott Kingwood located at 130 Northpark Plaza Drive.

There will be Fantastic raffle prizes from all over the Houston area as well as live entertainment provided by Atascocita High School orchestra/string quartet.

Guests can enjoy hors doeuvres and desserts by Kroger and a cash bar with entertainment. The event is presented by Kroger & Tracy Montgomery Team Keller Williams

Please RSVP to susieellen@hotmail.com or call Susie Ellen at 281-384-0903 or visit http://www.facebook.com/TeamBMultipleSclerosis.

More here:
Team B hosts A Night at the Hive fundraiser for Multiple Sclerosis

MS runner ends 7-day half-marathon

September 30th, 2014 by Rimaslarriarf No comments »

A woman who was diagnosed with MS in 2001, completes her first half-marathon, a week after starting it.

Continued here:
MS runner ends 7-day half-marathon

Can Diet Affect Multiple Sclerosis?

September 30th, 2014 by NalFeannyGege No comments »

By Sue Hughes Medscape Medical News

Sept. 25, 2014 — A new study of dietary patterns and risk for multiple sclerosis finds no relationship between eating a high-quality, healthy diet and a lower risk of getting MS.

Although the researchers looked at the diets from 185,000 women participating in other large studies, they focused on diets in adults only. It’s possible that diet in adolescence may be more important regarding risk for MS.

Dalia Rotstein, MD, from Brigham and Women’s Hospital in Boston, says that “further research is required to determine the possible role of dietary quality in the early years.

She presented the research at MS Boston 2014, the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis meeting.

Still, other studies presented at the same session of the conference showed that people with MS who also had other medical conditions have more MS disability. With this in mind, Rotstein tells Medscape Medical News, “We do know that healthy diet can help people in general and reduce other [conditions in people who have MS], especially cardiovascular disease, so this will help MS in the long run.”

Another study presented at the meeting showed no effect of a plant-based diet very low in saturated fat on MS, although numbers of people in the study were small.

It was linked to less fatigue, though, along with improvements in body mass index and total cholesterol. This caused the researchers to conclude that “a diet very low in saturated fats may yield longer-term quality-of-life benefits and vascular health benefits” in people with MS.

On this point, Rotstein says obesity in adolescence has shown a strong link to a greater risk of getting MS. But studies in adults have been more mixed, and obesity in adults has not been definitely linked with an increased MS risk.

“Our study was conducted purely in adults, with a youngest age of 25,” she says. “All we can say from our results is that there does not appear to be a direct relationship between diet quality and risk of developing MS as an adult. We cannot say anything about eating habits in adolescence and risk of MS from these data. It is possible that the adolescent years are a critical window, but our study doesn’t answer that question.”

Read more:
Can Diet Affect Multiple Sclerosis?

Invitation – Quebec Summit on Multiple Sclerosis – Discover the latest Quebec research projects on multiple sclerosis!

September 30th, 2014 by jogilot No comments »

MONTREAL, Sept. 23, 2014 /CNW Telbec/ – Research on multiple sclerosis is progressing in leaps and bounds, and Quebec is undeniably contributing to advances in this field; Come and meet eminent health care specialists and learn the very latest news on the results of research into the disease at the Quebec Summit on Multiple Sclerosis, organized by the Multiple Sclerosis Society of Canada, which …

See the rest here:
Invitation – Quebec Summit on Multiple Sclerosis – Discover the latest Quebec research projects on multiple sclerosis!

Sarthak – Autologous Bone Marrow Cell Transplantation in CP with Sensory Neural Deafness – Video

September 30th, 2014 by buy latisse No comments »



Sarthak – Autologous Bone Marrow Cell Transplantation in CP with Sensory Neural Deafness
stem cell india, stem cell therapy india, stem cell in india, stem cell therapy in india, india stem cell, india stem cell therapy.

By: Stem Cell India

View original post here:
Sarthak – Autologous Bone Marrow Cell Transplantation in CP with Sensory Neural Deafness – Video

Stem Cell Therapy in Muscular Dystrophy – Woman – Video

September 30th, 2014 by jeywoody No comments »



Stem Cell Therapy in Muscular Dystrophy – Woman
stem cell india, stem cell therapy india, stem cell in india, stem cell therapy in india, india stem cell, india stem cell therapy.

By: Stem Cell India

Visit link:
Stem Cell Therapy in Muscular Dystrophy – Woman – Video

Stroke Stem Cell Therapy Testimonial – Video

September 30th, 2014 by Olpulordyxmom No comments »



Stroke Stem Cell Therapy Testimonial
Kylie tells the story of her father's stroke and how stem cell therapy helped his condition.

By: stemaid

Originally posted here:
Stroke Stem Cell Therapy Testimonial – Video

Stem cell therapy for pets available in Huntsville

September 30th, 2014 by michell137 No comments »

HUNTSVILLE, Ala. (WAAY) — We hate to see our elderly loved ones start having trouble getting around. The same goes for our pets. They’re part of the family too. Now there’s a procedure that could help pets across the valley, in just one day.

For Tasha, Wednesday was a big day. The 12 year old black lab has a tough time getting around. She has hip dysplasia and arthritis. But this visit to Whitesburg Animal Hospital, should change that.

“In a week, they’re better. Even in the first day or two, you’ll see noticeable improvement,” says Whitesburg veterinarian Dr. Mark Russell.

The hospital teamed up with MediVet America to offer a one-day stem cell procedure, the first in North Alabama. It can now activate sleeping stem cells in an animal’s fat, then inject them right back into the damaged areas.

“The stem cells will repair and regenerate cartilage, tendons, whatever is lacking in that area,” says Trey Smith, the Director of Lab Services for MediVet America.

In the past, the cells had to be sent to California to be activated. This quicker procedure has another benefit.

“We’ve relied on medications to try to control this, and that’s pretty much all we had. And you get to a certain point, when the medication doesn’t work anymore, and their quality of life is bad. That’s not hardly worth it for them. This gives them a whole new option,” Dr. Russell says.

“Probably 20 to 25 percent of dogs are arthritic and they’re not very good at telling their owner they’re hurting,” adds Smith.

So, what should you look for?

Russell says, “When your pet starts slowing down, it may not be because they’re getting older, it may be because they’re hurt.”

Follow this link:
Stem cell therapy for pets available in Huntsville